Description |
1 online resource |
Contents |
Controlling Dangerous Pathogens -- Copyright -- ACRONYMS -- Contents -- Preface -- Executive Summary -- CONTEXT -- THE IMPORTANCE OF U.S.-RUSSIAN COOPERATION ON DANGEROUS PATHOGENS -- ESTABLISHING THE BASIS FOR EXPANDED COOPERATION -- PHASE 1: A PATHOGENS INITIATIVE -- PHASE 2: AN ERA OF SUSTAINED COOPERATION FOLLOWING THE PATHOGENS INITIATIVE -- COSTS -- Pathogens Initiative -- Phase 2: An Era of Longer-Term Sustained Cooperation -- ANTICIPATED RESULTS OF THE PROGRAM -- 1 The Context for a Program of Bilateral Cooperation -- THE DUAL-USE DIMENSION OF BIOTECHNOLOGY |
|
INTERNATIONAL RESPONSE TO THE BW THREAT -- THE SPECIAL CASE OF RUSSIA -- THE IMPORTANCE OF U.S.-RUSSIAN COOPERATION ON DANGEROUS PATHOGENS -- Transparency as a Response to Risk -- Benefits -- The Need for Coordination of U.S. Government Efforts -- THE BLUEPRINT FOR COOPERATION -- 2 Establishing the Basis for Long-Term Cooperation -- IMPORTANCE OF RUSSIAN PARTICIPATION IN JOINT PLANNING -- PLANNING FOR SUSTAINED COOPERATION IN THE LONG-TERM -- INITIAL PILOT PROJECTS -- Selection of the Institutes -- Selection of the Initial Projects -- Use of the ISTC Mechanism -- Value Added by the NAS Committee |
|
INSIGHTS FROM THE PILOT PROJECTS -- PRINCIPLES TO GUIDE BILATERAL COOPERATION -- ORGANIZING RESEARCH ACTIVITIES IN THE FUTURE -- Criteria for Judging Research Proposals -- Size and Scope of Research Projects -- Financial Realities -- A GOOD BASIS FOR FUTURE COOPERATION -- 3 Phase 1: A Pathogens Initiative to Expand Cooperation -- A WINDOW OF OPPORTUNITY FOR INITIATING JOINT EFFORTS -- RECOMMENDATION FOR A PATHOGENS INITIATIVE -- Organizational Structure -- Research Collaboration -- Framework for the Effort -- Involving Additional Russian Institutions -- Supporting Activities |
|
Project Development Activities -- Estimated Cost -- Anticipated Results -- 4 Phase 2: An Era of Sustained Cooperation -- THE UNCERTAIN FUTURE OF RUSSIA -- A MODEL FOR SUSTAINED COOPERATION -- ORGANIZATIONAL ARRANGEMENTS FOR A PHASE 2 PROGRAM -- GENERAL CHARACTERISTICS OF PHASE 2 -- TECHNICAL ASPECTS OF THE PROGRAM -- Research Collaboration -- Epidemiology -- Biosafety -- ESTIMATED COSTS -- ANTICIPATED BENEFITS -- A Committee and Staff Biographies -- COMMITTEE MEMBERS -- STAFF MEMBERS -- B Extract from Statement of Work of DOD/NAS Contract -- SCOPE -- OBJECTIVES -- C Consultations and Visits |
|
CONSULTATIONS IN UNITED STATES -- CONSULTATIONS AND VISITS IN RUSSIA -- D Protocol for the Prohibition of the Use in War of Asphyxiating, Poisonous, or Other Gases, and of Bacteriological Methods -- E Convention on the Prohibtion of the Development, Production, and Stockpiling of Bacteriological (Biological) and Toxin -- ARTICLE I -- ARTICLE II -- ARTICLE III -- ARTICLE IV -- ARTICLE V -- ARTICLE VI -- ARTICLE VII -- ARTICLE VIII -- ARTICLE IX -- ARTICLE X -- ARTICLE XI -- ARTICLE XII -- ARTICLE XIII -- ARTICLE XIV -- ARTICLE XV -- F Australia Group |
Notes |
Title from content provider |
Subject |
Biological arms control -- United States
|
|
Biological arms control -- Russia (Federation)
|
|
Biological arms control -- International cooperation
|
|
Biological arms control
|
|
Biological arms control -- International cooperation
|
|
Russia (Federation)
|
|
United States
|
Form |
Electronic book
|
Author |
U.S.-Russian Collaborative Program for Research and Monitoring of Pathogens of Global Importance Committee, National Academy of Sciences, Institute of Medicine, and National Research Council
|
|